HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Monday, 13 August 2012

Recent CUAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  13 papers were listed this time. Here's a few in our areas of research interest:

Chan Lee W, Samyshkin Y, Langer J, Palmer JL. Long-term clinical and economic outcomes associated with liraglutide versus sitagliptin therapy when added to metformin in the treatment of type 2 diabetes: a CORE Diabetes Model analysis. J Med Econ. 2012 Jul 26. [Epub ahead of print] PubMed PMID: 22834986.

Toy M, Onder FO, Idilman R, et al. The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country. Eur J Health Econ. 2012 Jul 20. [Epub ahead of print] PubMed PMID: 22815098.

Pfohl M, Schädlich PK, Dippel FW, et al. Health economic evaluation of insulin glargine versus NPH insulin in intensified conventional therapy for type 1 diabetes in Germany. J Med Econ. 2012 Jul 19. [Epub ahead of print] PubMed PMID: 22812690.